Cargando…
Glucocorticosteroid in Treatment of Severe Pneumonia
Airway diseases such as pneumonia constitute a major health burden on a global scale; untreated pneumonia may develop to severe pneumonia and consequently lead to to fatal episodes of mortality and morbidity. The balance between inflammatory mediators is key for the outcome of the pulmonary infectio...
Autores principales: | Ariani, Felinda, Liu, Kaixiong, Jing, Zhang, Qu, Jieming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865735/ https://www.ncbi.nlm.nih.gov/pubmed/24363503 http://dx.doi.org/10.1155/2013/865635 |
Ejemplares similares
-
Probiotics for Preventing Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials
por: Wang, Jie, et al.
Publicado: (2013) -
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022) -
Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017) -
THE RETROSPECTIVE ANALYSIS OF GLUCOCORTICOSTEROIDS USE IN THE TREATMENT OF SARS IN BEIJING
por: Wang, Guangfa, et al.
Publicado: (2007) -
THE EFFECT OF GLUCOCORTICOSTEROIDS ON THE KINETICS OF MONONUCLEAR PHAGOCYTES
por: Thompson, Jan, et al.
Publicado: (1970)